What is the latest price of Alpelisib?

Alpelisib (Alpelisib) is an oral drug that is a PI3K (phosphatidylinositol-3-kinase) inhibitor among protein kinase inhibitors. It is primarily used to treat breast cancers that carry specific genetic mutations, specifically, advanced or metastatic breast cancers that are hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-).

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.

PI3K is an enzyme that plays a key role in cells and is involved in regulating cell growth, differentiation and survival. In some cancers, including breast cancer, the PI3K pathway may be abnormally activated, prompting uncontrolled growth of tumor cells. By inhibiting the α isoform of PI3K, Apelix interferes with this abnormal signaling pathway, thereby hindering the growth and spread of cancer cells.

The application of Apelvis is mainly based on the detection results of PIK3CA gene mutation. PIK3CAGene mutation is one of the most common molecular mutations in breast cancer patients, and the development and use of Apelvis can more accurately target this specific subgroup of patients and improve the level of individualization of treatment.

However, Apelvis is not without side effects, and some common adverse reactions include hyperglycemia, skin inflammation, diarrhea, etc. Therefore, during the use of Apelvis, doctors need to monitor and manage according to the patient's specific situation to ensure patient safety and good therapeutic effects.